Tuesday, August 9, 2022
Advertisement
sk:n plans to continue growth strategy under ownership of TriSpan

Cosmetic surgery market buoyant for MYA

The cosmetic surgery market was buoyant in 2017, according to Harrogate-based provider MYA Cosmetic Surgery. The company reported an 14% jump in turnover to £21.5m...

Decline in NHS activity pushes income down 9% at HMT

The Healthcare Management Trust (HMT) has said reductions in both NHS activity and NHS tariff prices were behind a 9% drop in total income...

Medvivo results

Out-of-hours care provider Medvivo has reported a 4% rise in revenue to £14.2m for the year ended 30 June 2017. Cost of sales were broadly...

Assura reaps the benefits of scale

UK Reit and primary care property investor Assura Group today announced a 22.3% jump in its rent roll to £91m as it reaped the benefits...

Spire committed to new strategy despite setbacks in H1

Spire Healthcare said today (18 September) that it remains committed to its five-year plan of achieving significant increases in self-pay and EBITDA, despite suffering...

3fivetwo reports dip in turnover but figures hint at recovery

Northern Ireland’s largest private healthcare provider 3fivetwo Medical Group has reported further decline in turnover but said it is expecting growth to return following...

Strong growth in patient numbers drives performance at Calea

Calea UK, the home healthcare and pharmaceutical business owned by Fresenius, reported a 16% leap in turnover to £62.6m in the year to 31...
Fertility experts urge IVF clinics to share success rates

CREATE returns to family-run business after buying out Livingbridge

CREATE Fertility today announced that it has bought out its minority private equity investor Livingbridge and plans to pursue its ambitious European growth strategy...

Vanguard moves into Australian market

Mobile operating theatre specialist Vanguard Healthcare Solutions has launched an Australian subsidiary as part of its international growth strategy. Q-bital Healthcare Solutions pty Ltd was...

Advanced Oncotherapy ups final tranche of fundraise

Advanced Oncotherapy said today that high levels of investor demand had caused it to increase the size of its open offer by 16%. It now...